» Articles » PMID: 21072904

STAT-3 Correlates with Lymph Node Metastasis and Cell Survival in Gastric Cancer

Overview
Specialty Gastroenterology
Date 2010 Nov 13
PMID 21072904
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the correlation between gastric cancer growth and signal transducer and activator of transcription-3 (STAT3) expression.

Methods: We assessed the expressions of STAT3, phosphor-STAT3 (pSTAT3), suppressor of cytokine signaling-1 (SOCS-1), survivin and Bcl-2 in gastric cancer patients after gastrectomy by immunohistochemical method. In addition, in situ hybridization was used to further demonstrate the mRNA expression of STAT3 in gastric cancer.

Results: With the univariate analysis, expressions of STAT3, pSTAT3, SOCS-1, survivin and Bcl-2, the size of primary tumor and the lymph node metastasis were found to be associated with the overall survival (OS) of gastric cancer patients. However, only pSTAT3 expression and the lymph node metastasis were identified as the independent factors of OS of gastric cancer with multivariate analysis. STAT3 expression was correlated with the lymph node metastasis. There were positive correlations between expressions of STAT3, survivin, Bcl-2 and pSTAT3 in gastric cancer, whereas there was negative correlation between STAT3 expression and SOCS-1 expression in gastric cancer.

Conclusion: STAT3 can transform into pSTAT3 to promote the survival and inhibit the apoptosis of gastric cancer cells. SOCS-1 might be the valid molecular antagonist to inhibit the STAT3 expression in gastric cancer.

Citing Articles

Clinicopathological significance of JAK2, STAT3, and STAT4 expression in patients with gastric solid-type poorly differentiated adenocarcinoma: a retrospective study.

Umekita S, Kiyozawa D, Honma H, Kohashi K, Taniguchi Y, Kawatoko S Gastric Cancer. 2025; .

PMID: 39961990 DOI: 10.1007/s10120-025-01589-8.


Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer.

Tian Y, Xie Y, Yi G, Wu F, Dang X, Bai F Curr Med Chem. 2024; 31(42):7043-7058.

PMID: 39129286 DOI: 10.2174/0109298673315146240731100101.


Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines.

Huber A, Allam A, Dijkstra C, Thiem S, Huynh J, Poh A Cell Rep. 2024; 43(8):114616.

PMID: 39128004 PMC: 11372443. DOI: 10.1016/j.celrep.2024.114616.


The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.

Zhao R, Hu Z, Zhang X, Huang S, Yu G, Wu Z Cell Commun Signal. 2024; 22(1):68.

PMID: 38273295 PMC: 10809652. DOI: 10.1186/s12964-023-01421-9.


Study on the Mechanism of Action of STAT3 in the Drug Resistance of Gastric Cancer Cells.

Di J, Jiang B, Shang H, Yang X, Zhang C, Shi X Contrast Media Mol Imaging. 2022; 2022:1426343.

PMID: 35992548 PMC: 9356858. DOI: 10.1155/2022/1426343.


References
1.
Jackson C, Giraud A . STAT3 as a prognostic marker in human gastric cancer. J Gastroenterol Hepatol. 2009; 24(4):505-7. DOI: 10.1111/j.1440-1746.2009.05822.x. View

2.
Scholz A, Heinze S, Detjen K, Peters M, Welzel M, Hauff P . Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology. 2003; 125(3):891-905. DOI: 10.1016/s0016-5085(03)01064-3. View

3.
Vidal O, Soriano-Izquierdo A, Pera M, Elizalde J, Palacin A, Castells A . Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers. J Gastrointest Surg. 2007; 12(6):1005-14. DOI: 10.1007/s11605-007-0336-3. View

4.
Starr R, Willson T, Viney E, Murray L, Rayner J, Jenkins B . A family of cytokine-inducible inhibitors of signalling. Nature. 1997; 387(6636):917-21. DOI: 10.1038/43206. View

5.
Chan A, Luk J, Hui W, Lam S . Molecular biology of gastric carcinoma: from laboratory to bedside. J Gastroenterol Hepatol. 2000; 14(12):1150-60. DOI: 10.1046/j.1440-1746.1999.02000.x. View